Funds holding ADIAL PHARMACEUTICALS INC
4 funds declare a position · 0 ETFs and 4 other funds · 15.7K $ · US00688A3041
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 5,277 | 13.4K $ | as of Feb 28, 2026 · Original filing | |
| 2 | Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 366 | 926 $ | as of Feb 28, 2026 · Original filing | |
| 3 | VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 361 | 646.2 $ | as of Mar 31, 2026 · Original filing | |
| 4 | Fidelity Total Market Index Fund Fidelity Concord Street Trust | 310 | 784.3 $ | as of Feb 28, 2026 · Original filing |
Institutional managers
12 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 24,249 | 43.4K $ | as of Mar 31, 2026 |
| Manchester Capital Management LLC | 1,923 | 3.4K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 1,356 | 2.4K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 1,110 | 2K $ | as of Mar 31, 2026 |
| UBS Group AG | 542 | 970 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 50 | 90 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 47 | 84 $ | as of Mar 31, 2026 |
| Caitong International Asset Management Co., Ltd | 15 | 27 $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 6 | 11 $ | as of Mar 31, 2026 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 4 | 7 $ | as of Mar 31, 2026 |
| HARBOUR INVESTMENTS, INC. | 3 | 5 $ | as of Mar 31, 2026 |
| Abound Wealth Management | 1 | 2 $ | as of Mar 31, 2026 |